Fundz

Cambrian Bio Pharma Inc reported raising $28.4 Million in an initial SEC Form D filing, from an offering of $28.4 Million

PRIVATEMay 06, 2021

Amount Raised

$28.4 Million

$28.4 Million sold, per SEC Form D (first sale May 6, 2021)

Round Type

Venture

New YorkBiotechnologyHealthcare

Quick answer

Cambrian BioPharma raised $28.4 Million in a funding round, dated May 6, 2021. Cambrian BioPharma is based in New York, New York, United States.

How much did Cambrian BioPharma raise?
Cambrian BioPharma raised $28.4 Million in a funding round on May 6, 2021.
What does Cambrian BioPharma do?
Cambrian Biopharma is building the medicines that will redefine healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent in good health.
Where is Cambrian BioPharma based and how big is it?
Cambrian BioPharma is based in New York, New York, United States. Fundz records about 30 employees.
Who are the decision-makers at Cambrian BioPharma?
Fundz holds 1 contact at Cambrian BioPharma, including the Executive Officer, Director, Promoter. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as Cambrian BioPharma that raised within 45 days of this round, from Fundz verified event records.

Who to call at Cambrian BioPharma, and when

A new round usually means Cambrian BioPharma is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Cambrian BioPharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cambrian BioPharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cambrian BioPharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cambrian BioPharma

Location

228 PARK AVENUE S.

New York, New York, United States

About

Cambrian Biopharma is building the medicines that will redefine healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent in good health. As a Distributed Development Company (or DisCo), Cambrian is advancing multiple scientific breakthroughs each targeting a biological driver of aging. Our approach is to develop interventions that treat specific diseases first, then deploy them as preventative medicines to improve overall quality of life as we age. To date, Cambrian has 14 novel therapeutics in development across its majority-held pipeline companies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cambrian BioPharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsJames P., Executive Officer, Director, PromoterSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Cambrian BioPharma's next move

See what Strategic adds

Cambrian BioPharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.